Literature DB >> 3004700

Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC-26) in BALB/c mice.

P Singh, J P Walker, C M Townsend, J C Thompson.   

Abstract

We recently reported trophic response of transplantable mouse colon cancer cells (MC-26) to pentagastrin, in vivo, and demonstrated gastrin receptors on MC-26 cells, in vitro. In the present study, growth of MC-26 cells in mice, in response to pentagastrin, was studied in relation to binding kinetics and capacity of gastrin receptor. Gastrin receptor levels on mouse fundic and colonic membranes and on MC-26 cellular membranes were determined before MC-26 cell inoculation and designated as Day 0 levels. Four groups of mice were next inoculated with MC-26 cells and given injections of either pentagastrin (treated) or normal saline (control) for 10 or 15 days. At the end of the treatment periods, body, tumor, fundic, and colon weights were noted and gastrin receptor measured. tumor and fundic weights increased significantly within 15 days of pentagastrin treatment, compared to control values. In control (non-pentagastrin treated) mice, the binding affinity of gastrin receptor on tumor membranes was significantly decreased and associated with the complete loss of high-affinity gastrin receptor (Kd = less than 0.5 nM) by Day 15 of tumor growth. On the other hand, both the binding affinity and gastrin receptor levels of tumor membranes were maintained at Day 0 values by pentagastrin treatment. Endogenous gastrin was therefore ineffective in maintaining high-affinity gastrin receptor on control tumors. A significant number of low-affinity gastrin-binding sites (Kd = less than 2 nM) appeared in control tumors by Day 15, which could reflect rapid dedifferentiation or conformational changes of gastrin receptor in the absence of high levels of normal regulatory hormones. These studies demonstrate that the trophic effects of gastrin on MC-26 cells are probably mediated by its regulation and maintenance of the binding affinity and capacity of gastrin receptor on the cancer cells, in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004700

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  IGF-I and IGF-I receptor in mouse colon cancer cells.

Authors:  P Singh; Y S Guo; S Narayan; Y Chandrasekhar
Journal:  In Vitro Cell Dev Biol       Date:  1991-10

2.  Characterization of gastrin binding to colonic mucosal membranes of guinea pigs.

Authors:  S Narayan; L Chicione; P Singh
Journal:  Mol Cell Biochem       Date:  1992-06-26       Impact factor: 3.396

3.  TGF-beta signaling in colon cancer cells.

Authors:  Fazhi Li; Yanna Cao; Courtney M Townsend; Tien C Ko
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

4.  Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer.

Authors:  Beat M Künzli; Maria-Isabell Bernlochner; Stephan Rath; Samuel Käser; Eva Csizmadia; Keiichi Enjyoji; Peter Cowan; Anthony d'Apice; Karen Dwyer; Robert Rosenberg; Aurel Perren; Helmut Friess; Christoph A Maurer; Simon C Robson
Journal:  Purinergic Signal       Date:  2011-04-02       Impact factor: 3.765

5.  Differences in plasma gastrin, CEA, and CA 19-9 concentration in patients with proximal and distal colorectal cancer.

Authors:  Grzegorz Bombski; Anita Gasiorowska; Daria Orszulak-Michalak; Beata Neneman; Justyna Kotynia; Janusz Strzelczyk; Adam Janiak; Ewa Malecka-Panas
Journal:  Int J Gastrointest Cancer       Date:  2002

6.  Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics.

Authors:  Suman Kundu; Keke Fan; Mingli Cao; Daniel J Lindner; Ralph Tuthill; Lili Liu; Stanton Gerson; Ernest Borden; Taolin Yi
Journal:  Mol Cancer Ther       Date:  2010-08-03       Impact factor: 6.261

7.  Growth-promoting effects of gastrin on mouse colon cancer cells in vitro: absence of autocrine effects.

Authors:  Y S Guo; M Baijal; G F Jin; J C Thompson; C M Townsend; P Singh
Journal:  In Vitro Cell Dev Biol       Date:  1990-09

8.  Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.

Authors:  Suman Kundu; Keke Fan; Mingli Cao; Daniel J Lindner; Zhizhaung Joe Zhao; Ernest Borden; Taolin Yi
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

Review 9.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

10.  Postprandial hypergastrinaemia in patients with colorectal cancer.

Authors:  K Wong; K Beardshall; C M Waters; J Calam; G J Poston
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.